Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Motixafortide in Multiple Myeloma: NCT07101445 Clinical Landscape Report 2026
15 October 2026
NCT07101445 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Teclistamab in Multiple Myeloma: NCT07105059 Clinical Landscape Report 2026
15 October 2026
NCT07105059 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Disitamab Vedotin in HER2-Expressing Non-Muscle Invasive Bladder Neoplasms: NCT07100184 Clinical Landscape Report 2026
15 October 2026
NCT07100184 clinical landscape for HER2-Expressing Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and d…
9 min read
LCAR-F33S in Multiple Myeloma: NCT07100067 Clinical Landscape Report 2026
15 October 2026
NCT07100067 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SM-17 in Dermatitis, Atopic: NCT07103369 Clinical Landscape Report 2026
15 October 2026
NCT07103369 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BT02 in Multiple Myeloma: NCT07107204 Clinical Landscape Report 2026
15 October 2026
NCT07107204 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YTS-109 in Lupus Nephritis: NCT07104721 Clinical Landscape Report 2026
15 October 2026
NCT07104721 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CM 355 in Systemic Lupus Erythematosus: NCT07104344 Clinical Landscape Report 2026
15 October 2026
NCT07104344 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Daratumumab in Multiple Myeloma: NCT07107529 Clinical Landscape Report 2026
15 October 2026
NCT07107529 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Velinotamig in Multiple Myeloma: NCT07102706 Clinical Landscape Report 2026
15 October 2026
NCT07102706 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BT02 in Advanced Malignant Solid Neoplasm: NCT07107178 Clinical Landscape Report 2026
15 October 2026
NCT07107178 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
ONT01 in Lupus Nephritis: NCT07107659 Clinical Landscape Report 2026
15 October 2026
NCT07107659 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.